基因检测时代的中性粒细胞减少症：进展与挑战。
Neutropenia in the age of genetic testing: Advances and challenges.
机构信息
Dana Farber and Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts.
Department of Pediatrics, University of Massachusetts Medical School, Worcester, Massachusetts.
出版信息
Am J Hematol. 2019 Mar;94(3):384-393. doi: 10.1002/ajh.25374. Epub 2019 Jan 8.
Abstract
Identification of genetic causes of neutropenia informs precision medicine approaches to medical management and treatment. Accurate diagnosis of genetic neutropenia disorders informs treatment options, enables risk stratification, cancer surveillance, and attention to associated medical complications. The rapidly expanding genetic testing options for the evaluation of neutropenia have led to exciting advances but also new challenges. This review provides a practical guide to germline genetic testing for neutropenia.
摘要
确定中性粒细胞减少症的遗传原因可为精准医疗的医学管理和治疗方法提供信息。对遗传性中性粒细胞减少症的准确诊断可为治疗选择提供信息，能够进行风险分层、癌症监测并关注相关的医疗并发症。用于评估中性粒细胞减少症的基因检测选择的快速扩展带来了令人兴奋的进展，但也带来了新的挑战。本文为中性粒细胞减少症的种系基因检测提供了实用指南。
相似文献
1
Neutropenia in the age of genetic testing: Advances and challenges.
Am J Hematol. 2019 Mar;94(3):384-393. doi: 10.1002/ajh.25374. Epub 2019 Jan 8.
2
Molecular diagnosis and monitoring of leukemia and lymphoma.
Leuk Res. 1993 Dec;17(12):1073-8. doi: 10.1016/0145-2126(93)90166-i.
3
Genetic Predisposition to Myelodysplastic Syndrome in Clinical Practice.
Hematol Oncol Clin North Am. 2020 Apr;34(2):333-356. doi: 10.1016/j.hoc.2019.10.002. Epub 2020 Jan 6.
4
Proposal for the clinical detection and management of patients and their family members with familial myelodysplastic syndrome/acute leukemia predisposition syndromes.
Leuk Lymphoma. 2013 Jan;54(1):28-35. doi: 10.3109/10428194.2012.701738. Epub 2012 Jul 9.
5
Genetic predisposition to MDS: diagnosis and management.
Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):110-119. doi: 10.1182/hematology.2019000021.
6
[Leukemias and malignant lymphomas in children].
Ugeskr Laeger. 1999 Apr 12;161(15):2191-5.
7
Myeloid Neoplasms with Germline Predisposition: A New Provisional Entity Within the World Health Organization Classification.
Surg Pathol Clin. 2016 Mar;9(1):165-76. doi: 10.1016/j.path.2015.09.010.
8
Precision Medicine in Myelodysplastic Syndromes and Leukemias: Lessons from Sequential Mutations.
Annu Rev Med. 2017 Jan 14;68:127-137. doi: 10.1146/annurev-med-062915-095637. Epub 2016 Sep 7.
9
Hematopoietic growth factors in hematological malignancies.
J Assoc Physicians India. 1995;Suppl 3:5-10.
10
Practical considerations for diagnosis and management of patients and carriers.
Semin Hematol. 2017 Apr;54(2):69-74. doi: 10.1053/j.seminhematol.2017.04.002. Epub 2017 Apr 6.
引用本文的文献
1
Isolated Severe Neutropenia in Adults, Evaluation of Underlying Causes and Outcomes, Real-World Data Collected over a 5-Year Period in a Tertiary Referral Hospital.
Medicina (Kaunas). 2024 Sep 26;60(10):1576. doi: 10.3390/medicina60101576.
2
The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children: A Consensus Between the European Hematology Association and the EuNet-INNOCHRON COST Action.
Hemasphere. 2023 Mar 30;7(4):e872. doi: 10.1097/HS9.0000000000000872. eCollection 2023 Apr.
3
Identification of GFI1 mutations in adult patients with congenital neutropenia.
Ann Hematol. 2022 Dec;101(12):2771-2773. doi: 10.1007/s00277-022-04977-7. Epub 2022 Sep 16.
4
Outcomes for patients with severe chronic neutropenia treated with granulocyte colony-stimulating factor.
Blood Adv. 2022 Jul 12;6(13):3861-3869. doi: 10.1182/bloodadvances.2021005684.
5
Diagnosis and therapeutic decision-making for the neutropenic patient.
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):492-503. doi: 10.1182/hematology.2021000284.
6
Impaired myelopoiesis in congenital neutropenia: insights into clonal and malignant hematopoiesis.
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):514-520. doi: 10.1182/hematology.2021000286.
7
Gene Therapy to the Retina and the Cochlea.
Front Neurosci. 2021 Mar 17;15:652215. doi: 10.3389/fnins.2021.652215. eCollection 2021.
8
A Next-Generation Sequencing Test for Severe Congenital Neutropenia: Utility in a Broader Clinicopathologic Spectrum of Disease.
J Mol Diagn. 2021 Feb;23(2):200-211. doi: 10.1016/j.jmoldx.2020.10.014. Epub 2020 Nov 17.
9
Genetic predisposition to MDS: diagnosis and management.
Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):110-119. doi: 10.1182/hematology.2019000021.
10
Benign ethnic neutropenia.
Blood Rev. 2019 Sep;37:100586. doi: 10.1016/j.blre.2019.06.003. Epub 2019 Jun 21.
本文引用的文献
1
Donor-derived MDS/AML in families with germline mutation.
Blood. 2018 Nov 1;132(18):1994-1998. doi: 10.1182/blood-2018-07-861070. Epub 2018 Sep 19.
2
PSTPIP1-associated myeloid-related proteinemia inflammatory syndrome: A rare cause of childhood neutropenia associated with systemic inflammation and hyperzincemia.
Pediatr Blood Cancer. 2019 Jan;66(1):e27439. doi: 10.1002/pbc.27439. Epub 2018 Sep 10.
3
Further evidence for the involvement of in a Shwachman-Diamond-like syndrome and expansion of the phenotypic features.
Cold Spring Harb Mol Case Stud. 2018 Oct 1;4(5). doi: 10.1101/mcs.a003046. Print 2018 Oct.
4
Mutations in the gene cause severe congenital neutropenia as well as Shwachman-Diamond-like syndrome.
Blood. 2018 Sep 20;132(12):1318-1331. doi: 10.1182/blood-2017-12-820308. Epub 2018 Jun 18.
5
CD40 ligand deficiency causes functional defects of peripheral neutrophils that are improved by exogenous IFN-γ.
J Allergy Clin Immunol. 2018 Nov;142(5):1571-1588.e9. doi: 10.1016/j.jaci.2018.02.026. Epub 2018 Mar 5.
6
Recent advances in understanding hematopoiesis in Fanconi Anemia.
F1000Res. 2018 Jan 24;7:105. doi: 10.12688/f1000research.13213.1. eCollection 2018.
7
Gene correction of reversed Kostmann disease phenotype in patient-specific induced pluripotent stem cells.
Blood Adv. 2017 Jun 2;1(14):903-914. doi: 10.1182/bloodadvances.2016003798. eCollection 2017 Jun 13.
8
Recent advances in understanding the pathogenesis and management of reticular dysgenesis.
Br J Haematol. 2018 Mar;180(5):644-653. doi: 10.1111/bjh.15045. Epub 2017 Dec 21.
9
A novel SAMD9 mutation causing MIRAGE syndrome: An expansion and review of phenotype, dysmorphology, and natural history.
Am J Med Genet A. 2018 Feb;176(2):415-420. doi: 10.1002/ajmg.a.38557. Epub 2017 Dec 21.
10
New monogenic disorders identify more pathways to neutropenia: from the clinic to next-generation sequencing.
Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):172-180. doi: 10.1182/asheducation-2017.1.172.
Zotero 插件